Pharma Aids Limited (DSE:PHARMAID)

Pharma Aids Revenue

Pharma Aids had revenue of 123.25M BDT in the quarter ending March 31, 2026, with 20.79% growth. This brings the company's revenue in the last twelve months to 495.70M, up 18.93% year-over-year. In the fiscal year ending June 30, 2025, Pharma Aids had annual revenue of 438.09M with 4.00% growth.

• Revenue (ttm): 495.70M
• Revenue Growth: +18.93%
• P/S Ratio: 3.60
• Revenue / Employee: 5.27M
• Employees: 94
• Market Cap: 1.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	438.09M	16.85M	4.00%
Jun 30, 2024	421.23M	112.74M	36.54%
Jun 30, 2023	308.49M	-14.55M	-4.51%
Jun 30, 2022	323.05M	42.76M	15.25%
Jun 30, 2021	280.29M	10.72M	3.98%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error